Fimasartan Optimal Reduction Targeting Elevated Blood Pressure: the FORTE Study

NCT03254914 · clinicaltrials.gov ↗

COMPLETED

Status

3554

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

PROCEDURE: Home Blood Pressure

Sponsor

Boryung Pharmaceutical Co., Ltd